GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Myos Rens Technology Inc (NAS:MYOS) » Definitions » Inventory-to-Revenue

Myos Rens Technology (Myos Rens Technology) Inventory-to-Revenue : 2.93 (As of Sep. 2020)


View and export this data going back to 2010. Start your Free Trial

What is Myos Rens Technology Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Myos Rens Technology's Average Total Inventories for the quarter that ended in Sep. 2020 was $1.42 Mil. Myos Rens Technology's Revenue for the three months ended in Sep. 2020 was $0.49 Mil. Myos Rens Technology's Inventory-to-Revenue for the quarter that ended in Sep. 2020 was 2.93.

Myos Rens Technology's Inventory-to-Revenue for the quarter that ended in Sep. 2020 declined from Jun. 2020 (4.63) to Jun. 2020 (2.93)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Myos Rens Technology's Days Inventory for the three months ended in Sep. 2020 was 522.85.

Inventory Turnover measures how fast the company turns over its inventory within a year. Myos Rens Technology's Inventory Turnover for the quarter that ended in Sep. 2020 was 0.17.


Myos Rens Technology Inventory-to-Revenue Historical Data

The historical data trend for Myos Rens Technology's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myos Rens Technology Inventory-to-Revenue Chart

Myos Rens Technology Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.32 5.09 3.46 4.80 1.62

Myos Rens Technology Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.72 4.34 5.58 4.63 2.93

Competitive Comparison of Myos Rens Technology's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Myos Rens Technology's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myos Rens Technology's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Myos Rens Technology's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Myos Rens Technology's Inventory-to-Revenue falls into.



Myos Rens Technology Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Myos Rens Technology's Inventory-to-Revenue for the fiscal year that ended in Dec. 2019 is calculated as

Inventory-to-Revenue (A: Dec. 2019 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2018 ) + Total Inventories (A: Dec. 2019 )) / count ) / Revenue (A: Dec. 2019 )
=( (1.676 + 1.666) / 2 ) / 1.032
=1.671 / 1.032
=1.62

Myos Rens Technology's Inventory-to-Revenue for the quarter that ended in Sep. 2020 is calculated as

Inventory-to-Revenue (Q: Sep. 2020 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2020 ) + Total Inventories (Q: Sep. 2020 )) / count ) / Revenue (Q: Sep. 2020 )
=( (1.474 + 1.368) / 2 ) / 0.485
=1.421 / 0.485
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Myos Rens Technology  (NAS:MYOS) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Myos Rens Technology's Days Inventory for the three months ended in Sep. 2020 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2020 )/Cost of Goods Sold (Q: Sep. 2020 )*Days in Period
=1.421/0.248*365 / 4
=522.85

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Myos Rens Technology's Inventory Turnover for the quarter that ended in Sep. 2020 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2020 ) / Average Total Inventories (Q: Sep. 2020 )
=0.248 / 1.421
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Myos Rens Technology Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Myos Rens Technology's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Myos Rens Technology (Myos Rens Technology) Business Description

Traded in Other Exchanges
N/A
Address
45 Horsehill Road, Suite 106, Cedar Knolls, NJ, USA, 07927
Myos Rens Technology Inc is a US-based bio-nutrition and biotherapeutics company. It focuses on the discovery, development, and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. The company develops nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases such as Sarcopenia, Cachexia, and others.
Executives
Joseph Mannello director, officer: Chief Executive Officer C/O BREAN CAPITAL, LLC, 1345 AVENUE OF THE AMERICAS, 29TH FLOOR, NEW YORK NY 10105
Victor E Mandel director PO BOX 5962, WASHINGTON DC 20016
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Christopher Pechock director C/O MATLINPATTERSON GLOBAL ADVISORS INC, 520 MADISON AVE, NEW YORK NY 10022-4213
Christopher C Dewey director 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271
Louis J. Aronne director 4640 ADMIRALTY, SUITE 500, MARINA DEL RAY CA 90292
Eric Zaltas director 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ 07927
Andrew Joel Ponte director 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927
David J Matlin 10 percent owner
John Nosta director 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927
Zhengguang Lyu director 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Ren Ren director, 10 percent owner 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Rens Technology Inc 10 percent owner 150 DRAKE STREET ROOM 7F, POMONA CA 91767
Rens Agriculture Science & Technology Co, Ltd 10 percent owner 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019
Guiying Zhao director 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019

Myos Rens Technology (Myos Rens Technology) Headlines

From GuruFocus